Clinical Trials Logo
  1. Home
  2. Bipolar Disorders
  3. NCT02904083

Study of the Effectiveness of Specific Training of Health Professionals on Adherence in Bipolar Disorder — CONCORDE  

Bipolar Disorders Clinical Trial

Clinical Trial Summary

Bipolar disorders are common psychiatric disorders characterized by severe and recurrent symptomatic periods (Major Depressive Episode, mania, hypomania) and interictal periods characterized by persistent residual symptoms, impaired functioning and quality of life. In addition, the prognosis of bipolar disorder is aggravated by an increased risk of suicide and a high frequency of somatic comorbidities. Poor adherence is one of the major factors influencing the course of the disorder and one of the causes of ineffective treatments. Considering that between 20 and 60% of patients with bipolar disorder have problems with adherence. Adherence is modulated by a number of socio-demographic, clinical and neuropsychological factors. It is also modulated by the knowledge, beliefs and In addition, studies have shown that the reasons attributed to poor adherence are different depending on whether questioning patients or healthcare professionals. This fault diagnosis, assessment of the causes and "fit" into the reasons associated with poor adherence is an aggravating factor of the problem. However, this factor seems modifiable by better training of professionals. A team from Newcastle University in England has developed a training program for all health professionals to improve the diagnosis and understanding of compliance issues in bipolar patients and provide simple tools to fight against patients with this problem. The investigators assume that this training will improve medication adherence among outpatients by trained professionals.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02904083
Study type Interventional
Source Assistance Publique Hopitaux De Marseille
Contact Raoul Belzeaux, MD
Email raoul.belzeaux@ap-hm.fr
Status Not yet recruiting
Phase N/A
Start date June 2017
Completion date June 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05537376 - A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness N/A
Completed NCT00240721 - A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder Phase 3
Completed NCT02242669 - Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders N/A
Completed NCT01821469 - Functional Correlates of Bipolar Disorders and Effects of the Psychoeducation. an fMRI Study N/A
Completed NCT00888264 - A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder N/A
Completed NCT02807688 - Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses N/A
Completed NCT00253162 - A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol Phase 3
Completed NCT01729650 - Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor) N/A
Recruiting NCT02843906 - Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection? N/A
Completed NCT01377896 - The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours N/A
Completed NCT00453804 - Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) Phase 4
Terminated NCT00047567 - Open-label Adjunctive Zonisamide for Bipolar Disorder Phase 4
Completed NCT03028545 - Representations and Strategies for Recovery N/A
Completed NCT00156325 - Escitalopram as a Mood Stabilizer for Bipolar II Disorder Phase 2
Completed NCT06034769 - Oral and Jaw Health in Bipolar Patients
Terminated NCT02936466 - Evaluation of a Serious Game for Patients With Bipolar Disorder Involved in a Psychoeducation Group N/A
Completed NCT00845988 - Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders Phase 4
Completed NCT00257075 - A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder Phase 3
Recruiting NCT01188395 - Bipolar Disorder With Alcoholism in Han Chinese N/A
Completed NCT01188148 - Series Studies of Bipolar Disorder-Valproate add-on Memantine Phase 2/Phase 3